| Literature DB >> 23563241 |
Salvatore Santo Signorelli1, Massimiliano Anzaldi, Valerio Fiore, Saverio Candido, Roberto Di Marco, Katia Mangano, Cinzia Quattrocchi, Sergio Neri.
Abstract
Neopterin is a marker of macrophage activation that has exhibited high plasma levels in atherosclerotic diseases including coronary heart disease and critical limb ischemia. The role of neopterin in chronic peripheral arterial disease (PAD) has yet to be elucidated. In the present study, neopterin (Ν) serum concentrations were analyzed in asymptomatic (AsP) and symptomatic (SyP) patients with PAD as well as controls (C). In total 120 subjects, 40 AsP [ankle brachial index (ABI) ≤0.90], 40 SyP (ABI ≤0.90 plus pain in legs) and 40 controls (ABI >0.9) were enrolled. The results of the present study showed that neopterin plasma levels were statistically different among the groups. These findings demonstrated that activation of N‑mediated monocyte‑macrophage, was also observed in chronic PAD.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23563241 DOI: 10.3892/mmr.2013.1407
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952